Blog — Latest Peptide Articles - Page 6 of 15

Mizon全球发布7 Vegan Peptide Booster Serum：韩国经典护肤品牌的多肽复配新尝试

Applications

Peptide Proof Editorial

-

July 12, 2026

Mizon全球发布7 Vegan Peptide Booster Serum：韩国经典护肤品牌的多肽复配新尝试

韩国经典护肤品牌Mizon最近宣布在全球市场正式推出其首款以肽类为核心的精华液产品——7 Vegan Peptide Booster Serum。正如其名，这款精华液使用了七种不同肽类成分的复配配方，同时强调纯素配方和零动物成分的理念。Mizon选择在全球范围同步推出这款产品，而不是先在韩国本土试水再逐步扩展海外市场，这本身就是肽类护肤品需求全球化趋势的一个强烈信号。

Mizon在K-Beauty领域是一个有特殊地位的品牌。它不像COSRX或Innisfree那样走”大规模全球化”路线，但在功效护肤爱好者群体中一直有稳定的口碑。它的明星产品——蛇毒精华和蜗牛修复系列——多年来积累了忠实的用户群体。现在Mizon把目光投向肽类，说明肽类护肤已经从高端小众品牌的前沿概念变成了主流功效护肤品牌的必修课。

七肽复配：配方策略的深层逻辑

7 Vegan Peptide Booster Serum的配方逻辑与市面上的单肽或双肽产品有明显区别。七种肽类各有不同的信号功能：有的模拟胶原蛋白片段刺激纤维母细胞合成胶原，有的抑制神经递质释放达到类肉毒效果（类似Argireline的作用机制），有的则通过调节炎症因子帮助皮肤修复。Mizon选择七肽复配而不是集中资源打造一个独家肽分子，说明品牌的定位是”配方整合者”而非”原料发现者”。

但这里有一个关键问题需要客观看待：肽类复配并非越多越好。很多消费者会认为”七种肽一定比一种肽好”，但实际效果取决于每种肽的浓度是否达到了起效阈值。有些品牌为了在成分表上列出多种肽类名称，每种肽的添加量都远远低于有效浓度。Mizon没有公布每种肽的具体浓度，这是行业惯例，但对于理性消费者来说，选择肽类产品时关注品牌的口碑和配方历史，比单纯关注肽类数量更有参考价值。

那么七肽复配的价值到底体现在哪里？它真正的优势在于覆盖了更多护肤通路：信号肽、载体肽、神经递质抑制肽分别作用于不同的皮肤层面。如果配方中的每种肽都达到了有效浓度，这种多靶点策略确实比单肽产品有更全面的抗老效果。关键在于品牌是否有配方实力来实现这一点。

素食友好：肽类美容的伦理化趋势

这款产品另外值得关注的一点是它的纯素定位。传统护肤肽类的生产通常与动物组织或动物源性成分有关，但近年来越来越多的肽类原料实现了体外合成，完全脱离动物来源。Mizon选择在肽类产品上强调纯素概念，反映了肽类护肤市场正在经历的一个伦理化转型——消费者不仅关心肽类是否有效，还关心它的来源和生产方式。

这让肽类护肤产品与传统”抗老精华”产品线形成了差异化。当消费者面对琳琅满目的肽类精华液时，”纯素””零残忍””植物配方”这些标签提供了一种额外的决策简化的路径。

Mizon进入肽类赛道对市场意味着什么

当COSRX、Mizon、甚至Cetaphil和Neutrogena这样的大众品牌都在推出肽类产品线时，肽类护肤品的市场信号已经很明确：肽类正在从差异化卖点变成基础配方要求。就像十年前透明质酸从高端成分变成了每个品牌的基础保湿剂一样，肽类抗老正在经历同样的普及过程。对于消费者来说，这意味着未来会有更多价格层次的选择，但同时也意味着真正有技术含量的肽类产品需要更用心的甄别。

这件事我会持续跟踪。肽类市场的下一波竞争焦点，可能将从”用不用肽”转向”用什么样的肽、浓度够不够、配方能不能让它渗透到位”——那时才是真正考验品牌配方实力的时候。

延伸阅读

最后审阅：2026年7月。Peptide Proof编辑部。来源：Yahoo Finance，Glossy

COSRX推出蓝肽精华液：K-Beauty巨头如何在肽类护肤赛道再加码

Applications

Peptide Proof Editorial

-

July 12, 2026

0

韩国护肤品牌COSRX最近推出了一款名为Blue Peptide Serum的全新蓝肽精华液，主打肽类抗老与皮肤丰盈效果。这款精华液的核心成分是肽类复合物与补骨脂酚的组合——补骨脂酚作为视黄醇的天然替代品，近年来在温和抗老领域备受关注。更值得关注的是，COSRX在刚结束的Amazon Prime Day期间首次为这款产品推出了大额折扣，将Blue Peptide Serum与补骨脂酚精华打包促销，这是该品牌在肽类护肤领域最积极的一次市场动作。

COSRX并不是肽类护肤的新手。这家韩国品牌早已拥有多款含肽类成分的产品，包括其热销的肽类眼贴膜。但Blue Peptide Serum的推出标志着品牌在肽类领域的战略升级：不再只是将肽类作为辅助成分添加到现有产品线中，而是推出了以肽类为核心卖点的独立精华液产品。

COSRX为什么选择现在加码肽类？

答案隐藏在行业数据中。据美容市场研究机构Spate的数据，截至今年四月初，”peptide therapy”在Google上的年同比增长率达到百分之二百八十一，在TikTok上增长百分之四百五十九，在Instagram上增长百分之四百一十二。Spate预测未来一年肽类相关搜索还将继续增长百分之三十三。这些数字背后是一个明确的信号：肽类已经从科学家和生物骇客的小众话题，变成主流消费者的护肤关键词。

美容行业咨询师Lorne Lucree在接受Glossy采访时指出，肽类在美容领域的爆发可以追溯到K-18这个肽类护发品牌——它在二零二零年推出后迅速走红，二零二三年被联合利华以超过十亿美元收购。K-18的成功让整个行业重新认识到肽类在护肤和护发中的潜力。现在，原料供应商也在积极开发新型肽类成分，品牌获取优质肽原料的渠道比以往任何时候都多。

蓝肽精华液的核心竞争力在哪里？

Blue Peptide Serum的配方策略值得关注。它将肽类抗老功效与补骨脂酚的温和焕肤作用结合在一起，形成了多通路抗老的配方逻辑。肽类负责信号传导，刺激胶原蛋白生成；补骨脂酚则从另一个角度改善肤质和纹理。这种多靶点组合的思路在一瓶产品中实现了，省去了消费者分别购买和叠加的麻烦。

但这里有一个关键点很多人会忽视：肽类与其他活性成分的配伍问题。肽类分子在配方中相当敏感，尤其是与酸性成分共存时，其稳定性和生物利用度可能受到影响。补骨脂酚虽然比视黄醇温和，但它同样具有一定的pH敏感性。一款好的肽类产品，配方工程师需要在不破坏肽类活性的前提下，让多种成分协同工作。这不是所有品牌都能做到的。COSRX作为有多年配方积累的K-Beauty品牌，在这方面有天然优势。

那么这对普通消费者意味着什么？如果你正在寻找一款集抗老、焕肤、修护于一体的精华液，肽类加补骨脂酚的组合确实是一个高效的选择。但对于已经有视黄醇或A醇习惯的用户，需要注意不要过度叠加活性成分——给皮肤留出适应时间。

Prime Day促销背后的渠道策略

COSRX选择在Amazon Prime Day为Blue Peptide Serum推出首次促销，这个时机也有深意。Prime Day是跨境品牌证明其产品力的重要战场，能够在Prime Day获得好的销售表现，意味着产品获得了大量真实消费者的即时认可。COSRX将新款蓝肽精华液与已有的补骨脂酚精华捆绑销售，说明品牌正在积极将新老用户引导到肽类产品线上。

我在持续关注这个领域。肽类护肤在二零二六年已经从”差异化卖点”逐渐转变为”基础配方要求”。当越来越多的品牌推出肽类产品线，消费者真正需要的，是能讲清楚成分逻辑、配方经得起推敲的品牌——而这正是内容型电商可以发挥价值的地方。

延伸阅读

最后审阅：2026年7月。Peptide Proof编辑部。来源：Glossy，PR Newswire，Beauty Packaging

Peptide Therapy Trends Online as Beauty Brands Flood the Category

Applications

Peptide Proof Editorial

-

July 11, 2026

0

Peptide Therapy Trends Online as Beauty Brands Flood the Category

The beauty industry is in the middle of a peptide product explosion. Cosmetics Business reported eight new peptide-based product launches in a single month. That is not a slow trickle. That is a flood. And it is happening because consumers are actively searching for peptide ingredients in a way they never did before.

The term “peptide therapy” is trending across social media platforms. On TikTok, videos tagged with peptide skincare have accumulated over two billion views. On Instagram, peptide-related posts have grown by forty percent year over year. What started as a dermatologist-approved ingredient category has become a consumer-driven movement. Brands are responding by launching peptide products at every price point — from drugstore serums at fifteen dollars to clinical-grade treatments at two hundred dollars.

Eight New Launches Tell the Story

Cosmetics Business tracked eight new peptide product launches in the most recent reporting period. The products span multiple formats: serums, creams, eye treatments, masks, and even peptide-infused patches. The diversity of formats matters because it shows that brands are moving beyond the standard serum bottle. Peptide patches, for example, use a different delivery mechanism — occlusive adhesion that drives ingredients into the skin over several hours. That is a meaningful innovation.

The brands behind these launches range from indie startups to established luxury houses. What they share is a common ingredient strategy: multi-peptide complexes rather than single-peptide hero ingredients. The science supports this approach. Different peptides trigger different signaling pathways. A blend of Matrixyl, Argireline, and GHK-Cu covers collagen production, muscle relaxation, and tissue repair simultaneously.

Expert Insight

But here is what the trend data does not tell you. More products means more variability in quality. Peptide concentration matters enormously, and most brands do not disclose their concentrations on the label. That serum with “triple peptide complex” on the front could contain one percent of active peptides or zero point zero one percent — and you would not know the difference from the marketing copy. The only reliable signal is clinical testing. If the brand has published a peer-reviewed study, the concentration is probably meaningful. If not, you are paying for the label claim.

Peptide Patches: The New Frontier

One of the most interesting developments in this wave is the emergence of peptide patches. These are hydrogel or silicone patches infused with specific peptide complexes. You apply them to targeted areas — crow’s feet, nasolabial folds, forehead lines — and leave them on for four to eight hours. The occlusive environment increases peptide penetration by preventing water evaporation.

The data on peptide patches is still limited. Most evidence comes from small studies funded by manufacturers. But the mechanism is sound. A peptide sitting on the skin in a cream that evaporates in twenty minutes has less time to penetrate than a peptide held against the skin by an occlusive patch for eight hours.

What the Trend Means for Consumers

The peptide product explosion is good news for the category. More competition means better formulations and lower prices over time. But in the short term, it creates a lot of noise. Consumers need to look past the marketing and focus on three things: concentration transparency, clinical testing, and formulation stability. A peptide in a properly formulated product at the right concentration can produce visible results in eight to twelve weeks.

Why This Launch Matters for the Peptide Skincare Market

The US market for peptide skincare is at an inflection point. Consumer awareness has never been higher. Google searches for “peptide serum” have grown steadily over the past three years. But most products on the shelf use the same three or four well-known peptides. Matrixyl. Argireline. GHK-Cu. These ingredients work, but they have been around for years. The market needs differentiation.

NIBEC’s entry changes that calculation. The company is not a cosmetics brand that buys ingredients from Sederma or BASF. It is a biopharmaceutical company that spent decades developing growth factor therapies for wound healing and tissue regeneration. Now it is reformulating those same technologies for cosmetic use. That is a different level of science than what most peptide brands bring to the table.

Expert Insight

But here is what most people miss. Growth factors are harder to formulate than small peptides. They are larger molecules. They are more sensitive to pH, temperature, and preservatives. A growth factor serum that sits on a store shelf for eighteen months may have significantly less activity than the day it was manufactured. NIBEC’s patent portfolio includes stabilization technology, but the real-world stability testing matters more than the patent filing. Until independent labs verify the activity claims, treat the potency numbers as marketing, not science.

What This Means for the Broader Category

The bigger story here is about category evolution. Peptide skincare started with a few well-characterized matrikines. Then it expanded into copper peptides. Then into multi-peptide blends. Now it is moving into recombinant growth factors, which sit at the boundary between cosmetics and biologics. The FDA does not regulate growth factors in cosmetics the same way it regulates them in drugs. That regulatory gap creates a fast lane for innovation, but it also means consumers need to be more careful about what they buy.

KLARA Beauty launches with four products: a serum, a cream, an eye treatment, and a mask. All four use NIBEC’s proprietary growth factor complex. Pricing is in the premium range, between sixty and one hundred twenty dollars per product. Distribution is direct-to-consumer through the brand’s website.

The Stratum Corneum — Your Skin’s Brick Wall

The stratum corneum is the outermost layer of the epidermis. Think of it as a wall of flattened dead cells — corneocytes — packed tightly together and surrounded by lipid bilayers. This structure is brilliant at its job. It keeps water in and pathogens out. It also keeps peptides out.

The lipid matrix between corneocytes is the real gatekeeper. These lipids are highly organized into lamellar sheets that create a tortuous path for any molecule trying to pass through. A molecule must navigate around corneocytes through these narrow lipid channels. The path length is roughly ten to fifteen times the thickness of the stratum corneum itself.

For a molecule to cross this barrier passively, it generally needs three things. A molecular weight below five hundred daltons. A balanced preference for both oil and water environments — what chemists call a log P value between one and three. And no formal charge. Most cosmetic peptides fail on at least two of these criteria and often all three.

Why Peptides Have It Worse Than Other Actives

Peptides are chains of amino acids. The shortest cosmetic peptides contain three to five amino acids. That puts molecular weights in the four hundred to eight hundred dalton range — already at or beyond the passive diffusion limit. Longer peptides like acetyl hexapeptide-8, the famous Argireline, weigh in at around eight hundred ninety daltons.

Size is only the first problem. Most peptide sequences contain charged side chains — lysine, arginine, histidine, glutamic acid, aspartic acid. These charges make the peptide water-soluble. But water-soluble molecules partition poorly into the lipid domains of the stratum corneum. They get stuck on the surface.

There is a third problem that gets less attention. Human skin expresses proteolytic enzymes — peptidases — in the epidermis. These enzymes exist to break down peptide signals as part of normal skin turnover. They do not distinguish between a natural signaling peptide and a cosmetic one. A peptide sitting in the upper epidermis waiting to penetrate is also sitting in an enzymatic degradation zone.

Zdrada-Nowak and colleagues addressed all three of these barriers in a twenty twenty-five review published in the International Journal of Molecular Sciences. They focused on acetyl hexapeptide-8, which they described as hydrophilic with limited permeability through the lipophilic stratum corneum. The review concluded that despite promising cellular data and widespread commercial use, the ability of AH-8 to reach neuromuscular junctions after topical application remains uncertain.

The Numbers Don’t Lie — What Penetration Studies Actually Show

Researchers quantify skin penetration using Franz diffusion cells. These are glass chambers where a piece of excised human or porcine skin separates a donor compartment from a receptor compartment. The formulation goes on top. Whatever makes it through the skin gets collected and measured below.

Hoppel and colleagues at the University of Vienna ran exactly this experiment with acetyl hexapeptide-8 and published their results in the European Journal of Pharmaceutical Sciences. They tested three different emulsion types: a simple oil-in-water cream, a water-in-oil cream, and a complex water-in-oil-in-water multiple emulsion. LC-MS/MS was used for detection, so the measurements are precise down to the nanogram level. The multiple emulsion outperformed both simple emulsions significantly. The water-rich formulations generally outperformed the oil-rich ones.

Neubert and colleagues at Martin Luther University Halle-Wittenberg published an even more striking set of numbers in the European Journal of Pharmaceutics and Biopharmaceutics in twenty eighteen. They measured penetration of the tetrapeptide PKEK from a standard cream versus a nano-sized microemulsion. From the standard cream, forty to fifty-eight percent of the peptide penetrated into the skin. But here is the critical detail. The vast majority stayed in the stratum corneum. It never reached the viable epidermis where it could actually do something.

The microemulsion changed everything. After one hundred minutes, ninety-four percent of the PKEK had penetrated. After three hundred minutes, eighty-eight percent. And this time, a large proportion moved through all skin layers and into the receptor compartment. The nano-sized carrier did not just improve penetration. It fundamentally changed where the peptide ended up.

Chemical Solutions — Palmitoylation, CPPs, and Permeation Enhancers

There are three broad strategies for getting peptides through skin. Chemical modification changes the peptide itself. Carrier systems wrap the peptide in something that can cross. Physical methods punch temporary holes in the barrier.

Palmitoylation is the most common chemical strategy in commercial cosmetics. A sixteen-carbon fatty acid chain — palmitic acid — gets attached to the peptide’s amino terminus. This makes the peptide more lipophilic. It can now partition into the lipid matrix of the stratum corneum. Palmitoyl tripeptide-1, palmitoyl pentapeptide-4, and palmitoyl tetrapeptide-7 all use this approach. The palmitoyl tail is not just a delivery trick. It also helps the peptide anchor to cell membranes once it arrives, which may extend its functional half-life.

Mortazavi and Moghimi reviewed this strategy extensively. The data on palmitoylated peptides like KTTKS — the collagen-stimulating sequence in Matrixyl — showed that the lipid modification substantially improved skin permeation compared to the unmodified peptide. But here they also introduced an important caveat. Palmitoylation helps. It does not solve the problem completely. The modified peptide still faces size constraints and enzymatic degradation.

Cell-penetrating peptides represent a more radical chemical approach. These are short peptide sequences — typically rich in arginine — that evolved or were designed to cross biological membranes. Gautam and colleagues at the CSIR Institute of Microbial Technology in India published a striking demonstration in Scientific Reports in twenty sixteen. They fused a novel cell-penetrating peptide called IMT-P8 to green fluorescent protein — a molecule far larger than any cosmetic peptide. After topical application to mouse skin, the GFP was found in hair follicles and dermal tissue. The same team fused IMT-P8 to a pro-apoptotic peptide and confirmed it retained biological activity inside cells. One peptide acting as a shuttle for another peptide. This is delivery at a completely different level.

Chemical permeation enhancers are the simplest approach. Ethanol, propylene glycol, and various surfactants temporarily disrupt the lipid packing in the stratum corneum. They fluidize the barrier. The effect is modest but real, and many commercial peptide serums rely on these solvents for whatever penetration they achieve.

The Carrier Revolution — Microemulsions, Liposomes, and TRVs

Carrier systems do not change the peptide. They change the vehicle the peptide rides in. This category is where the most exciting recent work has happened.

Microemulsions are thermodynamically stable mixtures of oil, water, and surfactant that form droplets in the ten to one hundred nanometer range. The Neubert study with PKEK used this approach. The tiny droplet size creates an enormous surface area for interaction with the skin surface. The surfactant components help disrupt the lipid barrier. And because the droplets are water-continuous or bicontinuous, they can carry water-soluble peptides through an otherwise hostile lipid environment.

Moradi and colleagues published data in Dermatologic Surgery in twenty twenty-five on a next-generation carrier they call Tiered-Release Vesicles, or TRVs. These are multilamellar vesicles — concentric phospholipid bilayers wrapped around submicron emulsion droplets. The design creates staged release. Outer layers deliver first. Inner layers deliver later. It is the pharmaceutical equivalent of a time-release capsule applied to skin.

The numbers from their study are worth sitting with. TRV formulations delivered a large peptide two to five times more completely into ex vivo human skin than optimized conventional liposomes. For hyaluronic acid — a molecule far larger than any peptide — TRV delivery was three to thirteen times higher than a simple gel. They also published clinical case studies showing reduction of solar elastosis from a topical TRV formulation. That is a visible tissue-level outcome from topical delivery of macromolecules.

Liposomes themselves deserve mention, even though TRVs outperform them. A liposome is a spherical vesicle with a phospholipid bilayer surrounding an aqueous core. The bilayer mimics cell membranes, which allows fusion with the lipid domains of the stratum corneum. The aqueous core holds water-soluble peptides. Standard liposomes improve delivery modestly, typically by a factor of one-and-a-half to two over simple solutions. They are better than nothing. They are not the ceiling.

Physical Routes — Microneedles, Iontophoresis, and Laser-Assisted Delivery

Physical enhancement methods bypass rather than negotiate with the stratum corneum. Microneedles are the most practical for cosmetic use. Arrays of tiny needles — typically two hundred to seven hundred fifty microns long — create microscopic channels through the stratum corneum. The channels are too small to cause pain or bleeding. They are large enough for peptide-sized molecules to pass through.

Mortazavi and Moghimi’s review catalogued microneedle studies across multiple anti-wrinkle peptides. The enhancement ratios are substantial, often ten to one hundred times the passive penetration rate. The limitation is practical. Microneedling is a procedure, not a daily serum. But microneedle patches and at-home roller devices are bringing this closer to a consumer routine.

Iontophoresis uses a mild electric current to drive charged molecules through the skin. Since most peptides carry a net charge at physiological pH, they respond to an electric field. The current also temporarily reduces skin resistance by altering lipid packing. The combination of electrophoresis and barrier disruption produces reliable enhancement. It requires a device, which limits adoption for cosmetics. But the underlying physics is solid.

Laser-assisted delivery takes physical enhancement to the clinical level. Fractional ablative lasers create microscopic columns of destroyed tissue through the epidermis. These columns become highways for topical agents applied immediately after the laser pass. Khalifian and Shisler reviewed this approach in a twenty twenty-six article in Facial Plastic Surgery Clinics of North America. They described how fractional ablative and non-ablative laser systems overcome the stratum corneum barrier to facilitate substantive dermal penetration of bioactive peptides. This is not a home routine. It is a dermatology procedure. But it demonstrates what becomes possible when the barrier is temporarily removed.

Expert Insight — What the Formulation Labels Don’t Tell You

Here is the thing most experienced formulators know and most consumers do not. The peptide concentration printed on a label is the concentration in the bottle. It is not the concentration that reaches the dermis. The difference between those two numbers can be a factor of ten, fifty, or essentially infinite — meaning nothing gets through at all.

A common mistake even within the industry is treating all peptides as equivalent from a delivery perspective. GHK-Cu, the copper peptide, is relatively small at three hundred forty daltons. It has some inherent skin penetration because copper complexation alters its charge distribution. Acetyl hexapeptide-8 is nearly three times larger and far more hydrophilic. Formulating a one percent AH-8 serum in a simple water-glycerin base and calling it a day is, from a delivery standpoint, almost fraudulent. The peptide is sitting on the skin surface.

There is also a timeline reality that marketing language obscures. Most penetration studies measure accumulation over hours — not the thirty seconds between application and the next layer of moisturizer or sunscreen. If you apply a peptide serum and immediately layer something occlusive on top, you might actually be trapping the peptide in the upper stratum corneum rather than helping it penetrate deeper. The occlusion slows water evaporation, which keeps the stratum corneum hydrated. Hydrated corneocytes swell and narrow the intercellular lipid channels. That sounds like it would help. It often makes things worse for large hydrophilic molecules.

Cost is the final silent variable. A properly formulated peptide delivery system — a stable microemulsion, a TRV-based vehicle, a palmitoylated peptide at verified purity — costs significantly more to manufacture than a simple peptide-in-water solution. Brands that sell peptide serums for fifteen dollars are not using advanced delivery systems. They cannot afford to. The peptide they are using may be perfectly good. The vehicle carrying it almost certainly is not.

What This Means for Your Routine

You do not need a laser or a microneedle device to benefit from peptide skincare. But you do need to pay attention to the formulation, not just the ingredient list. Palmitoylated peptides are generally a safer bet than unmodified ones because the lipid tail does real work for penetration. Products that describe their delivery system — microemulsion, liposomal, multilayer vesicle — are signaling that the formulator thought about this problem. Products that do not describe their delivery system probably never solved it.

Application order matters too. Peptides should go on clean, slightly damp skin. Water briefly hydrates the stratum corneum and may improve penetration of water-soluble peptides through the resulting slight swelling of the corneocytes. Wait at least two to three minutes before applying anything on top. Give the peptide vehicle time to do its work before you layer another product over it.

And if you are using a product from Peptide Proof, the formulation question has been asked and answered. Our serums use palmitoylated peptides in vehicles designed with the skin barrier in mind. Not because it is the cheapest way. Because it is the only way that actually delivers.

Sources

Mortazavi SM, Moghimi HR. Skin permeability, a dismissed necessity for anti-wrinkle peptide performance. International Journal of Cosmetic Science. 2022 volume 44 issue 2 pages 232 to 248.
Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals — A Review of Skin Permeability and Efficacy. International Journal of Molecular Sciences. 2025 volume 26 issue 12 page 5722.
Moradi A, Bhatia AC, Behr K, Napekoski K, Foldvari M. In Vivo and Ex Vivo Evaluation of a Novel Method for Topical Delivery of Macromolecules Through the Stratum Corneum for Cosmetic Applications. Dermatologic Surgery. 2025 volume 51 issue 4 pages 403 to 408.
Neubert RHH, Sommer E, Schölzel M, Tuchscherer B, Mrestani Y, Wohlrab J. Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part II: Tetrapeptide PKEK. European Journal of Pharmaceutics and Biopharmaceutics. 2018 volume 124 pages 28 to 33.
Hoppel M, Reznicek G, Kählig H, Kotisch H, Resch GP, Valenta C. Topical delivery of acetyl hexapeptide-8 from different emulsions: influence of emulsion composition and internal structure. European Journal of Pharmaceutical Sciences. 2015 volume 68 pages 27 to 35.
Gautam A, Nanda JS, Samuel JS, Kumari M, Priyanka P, Bedi G, Nath SK, Mittal G, Khatri N, Raghava GP. Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8. Scientific Reports. 2016 volume 6 page 26278.
Khalifian S, Shisler J. Photobiomodulation and Biological Pathways in Skin Regeneration and Rejuvenation. Facial Plastic Surgery Clinics of North America. 2026 volume 34 issue 3 pages 471 to 485.

Kenvue推出Neutrogena Collagen Bank微肽技术：专利级肽类创新的新高度

Applications

Peptide Proof Editorial

-

July 11, 2026

0

Kenvue推出Neutrogena Collagen Bank微肽技术：专利级肽类创新的新高度

Kenvue，二〇二三年从强生分拆独立上市的消费者健康巨头，为其Neutrogena（露得清）品牌旗下的Collagen Bank系列推出了一项全新的专利微肽技术平台。这则发布于二〇二四年八月的消息，在二〇二六年看来更加意味深长——它展示了一个大型消费品公司如何用底层技术创新来布局肽类护肤品的未来。

为什么说这项技术值得关注？因为微肽（micro-peptide）不同于市面上大多数品牌使用的常规肽类成分。常规肽类通常由三到二十个氨基酸组成，而微肽的分子量更小，理论上透皮吸收的效率更高。Kenvue为这项技术申请了专利保护，意味着它在Neutrogena这个大众市场品牌的产品线中拥有了排他性的技术壁垒。

技术专利对肽类护肤品赛道意味着什么？

目前市面上绝大多数肽类护肤品使用的都是公开可得的肽类原料——比如Matrixyl、Argireline、GHK-Cu，这些成分由Sederma、Lipotec等原料供应商开发，任何品牌都可以购买和使用。但Kenvue的微肽技术走了另一条路：自主研发、专利保护、作为品牌的核心技术资产来运营。

数据背后反映出一个重要趋势：肽类护肤品的竞争正在从”谁用了肽类成分”向”谁拥有自己的肽类技术平台”升级。头部品牌不再满足于从供应商那里采购公开原料，而是开始建立自己的肽类研发能力。这一点在专业护肤领域已经在发生——ZO Skin Health今年一月也推出了肽类精华，强调”医疗美容后护理”的专业定位。

大众市场的肽类普及还有多远？

令人惊讶的是，尽管肽类护肤品的消费者认知在过去两年有了巨大提升，但大部分大众零售渠道的肽类产品仍然集中在高端线和专业线。Neutrogena在药妆店渠道推出Collagen Bank系列，定价在十五到三十美元区间，这可能是肽类护肤品进入真正大众市场的关键节点。

问题在于，大众市场的消费者教育和产品体验要求完全不同。专业线可以向消费者讲技术故事，但药妆店的消费者更看重”用了有没有效果”和”性价比如何”。这就给品牌提出了双重挑战：一是产品要在合理价位内实现可见效，二是需要把复杂的肽类技术翻译成消费者能理解的沟通语言。

这里有一个实用层面的观察：很多消费者在刚接触肽类护肤品时，经常问到的一个问题是”肽类和视黄醇能一起用吗？”答案是肯定的——事实上，肽类和视黄醇有互补作用，肽类支持胶原蛋白合成，视黄醇加速细胞更新，但要避免在同一护肤步骤中使用高浓度酸类产品，因为酸性环境可能影响肽类的稳定性。

Kenvue的这项微肽技术能否在Neutrogena的后续产品线中持续落地，将是一个重要的风向标。如果成功了，意味着我们很快会在更多大众零售渠道看到肽类护肤品，从药妆店到大型商超——这个品类的天花板将被大幅抬升。

延伸阅读

最后审阅：2026年7月。Peptide Proof编辑团队。信息来源：Glossy，Kenvue官方

Cetaphil推出Healthy Renew肽类抗衰老系列：温和护肤巨头首次押注肽类

Applications

Peptide Proof Editorial

-

July 11, 2026

0

Cetaphil推出Healthy Renew肽类抗衰老系列：温和护肤巨头首次押注肽类

Cetaphil，这个以温和、敏感肌护理闻名全球的大众护肤品牌，近日在印度市场推出了名为”Healthy Renew”的全新肽类抗衰老系列。这不是一次普通的产品线扩充——对于一家长期专注于基础保湿和温和清洁的品牌来说，这是Cetaphil首次进入肽类抗衰老领域，背后传递的信号远比一个产品发布本身更为重要。

注意这个时机。在肽类护肤品类经历了二〇二三年Goop、Glow Recipe和Naturium引领的第一波热潮，以及二〇二六年K-十八以十亿美元被收购的行业级验证之后，现在连Cetaphil这样的温和护肤品牌也加入战局。这意味着肽类已经从一个”差异化卖点”变成了”基础配方要求”。

Cetaphil为什么要做肽类抗衰老？

先来看看市场数据。据Glossy杂志今年四月的行业报道，肽类护肤品在谷歌搜索中的热度增长了百分之二百八十一，在TikTok上的话题增长更是高达百分之四百五十九。K-十八以十亿美元被收购的案例更是向整个美妆行业传递了一个清晰信号：消费者对肽类的认知和需求已经跨越了早期采用者的鸿沟。

Cetaphil在印度的这个动作特别有意思。印度市场正在经历快速增长的美妆消费升级，中产消费者对功效型护肤品的需求正在爆发。选择印度作为肽类抗衰老系列的首发市场，而不是欧美成熟市场，说明Cetaphil看准了新兴市场的增长潜力。

Cetaphil入局肽类赛道意味着什么？

问题在于，一个以”温和、安全、不刺激”为核心定位的品牌，如何在肽类抗衰老领域建立起消费者信任？肽类成分虽然比视黄醇刺激性低得多，但仍存在浓度与效果之间的平衡问题——浓度太低没效果，浓度太高可能引起敏感肌反应。

这里有一个行业公认的反向经验：很多品牌以为添加了肽类成分就万事大吉，但实际上肽类的稳定性、透皮吸收效率和与其他活性成分的配伍都直接影响最终效果。Cetaphil作为敏感肌领域的专家，能否在产品配方的温和性与功效性之间找到合适平衡点，将直接影响这个系列的成败。

不过从另一个角度看，Cetaphil的入局恰恰验证了肽类护肤品正在经历从”高端小众”到”大众普及”的转型。二〇二三年时，肽类还主要出现在Goop和Glow Recipe这样的中高端和K-Beauty品牌的产品线中。到了二〇二六年，从印度的Cetaphil到美国的Neutrogena，大众品牌纷纷加码肽类成分。

如果你自己也在尝试肽类护肤品，可能会注意到一个实用细节：肽类产品的效果通常需要连续使用四到八周才能显现，这和立即见效的填充剂完全不同。这也意味着，品牌需要做好消费者教育，管理好使用预期。

延伸阅读

最后审阅：2026年7月。Peptide Proof编辑团队。信息来源：Glossy，Google News

GHK-Cu Copper Peptide: How It Repairs Aging Skin

GHK-Cu

Peptide Proof Editorial

-

July 10, 2026

0

GHK-Cu Copper Peptide: How It Repairs Aging Skin

Copper peptide GHK-Cu is not hype. It is one of the few cosmetic ingredients with a forty-year paper trail showing exactly how it remodels aging skin at the molecular level. Discovered in human plasma in 1973 by Dr. Loren Pickart, this tiny tripeptide — just three amino acids bound to a copper ion — declines sharply with age. By the time you turn sixty, your plasma GHK levels have dropped to roughly twenty percent of what they were at twenty. And that drop matters because GHK-Cu is the body’s own signal for tissue repair. The question is not whether GHK-Cu works. The question is whether the version in your serum bottle can reach the right depth to do what the science says it can.

What GHK-Cu Actually Is

GHK stands for glycyl-L-histidyl-L-lysine — a tripeptide that occurs naturally in human plasma, saliva, and urine. When it binds a copper two-plus ion, it becomes GHK-Cu, and that is when the biology gets interesting. The copper is not a decorative add-on. It is the catalytic center. Without copper, the tripeptide is largely inert in skin. With copper, it activates a cascade of gene expression that touches at least four thousand human genes. Pickart’s foundational 2015 review in BioMed Research International documented this breadth — GHK-Cu simultaneously upregulates genes for collagen synthesis, elastin production, proteoglycan assembly, and antioxidant defense while downregulating inflammatory and fibrotic pathways. It is not a single-pathway ingredient like retinol or vitamin C. It is a systems-level reset signal.

The peptide is small enough — roughly three hundred forty daltons with copper — to theoretically cross the stratum corneum. But “theoretically” is the operative word. Copper carries a two-plus charge, and charged molecules face a much tougher barrier than neutral ones. More on that challenge shortly.

The age-related decline of GHK is well documented. A twenty-year-old has roughly two hundred nanograms of GHK per milliliter of plasma. A sixty-year-old has around forty. This is not a subtle drop. It is an eighty percent reduction in the body’s own tissue-repair signal. The biological logic of topical replacement follows directly: if declining GHK-Cu correlates with declining tissue repair, restoring it at the skin level should improve repair outcomes. The research backs this logic up, but the delivery mechanism — getting the peptide where it needs to go — is where most products fall short.

The Triad of Tissue Repair: How GHK-Cu Works

GHK-Cu repairs tissue through three coordinated mechanisms. No single one of them explains its effects. The triad is what makes it unique.

One: Extracellular Matrix Remodeling

The extracellular matrix, or ECM, is the scaffolding between your skin cells. It is made of collagen, elastin, and glycosaminoglycans — the molecules that give skin its structure, bounce, and hydration. As you age, this scaffolding degrades faster than your body can rebuild it. GHK-Cu flips that balance. It stimulates fibroblast cells to pump out collagen types one and three, elastin, and the small proteoglycan decorin. A 2026 study from LG Household and Health Care published in Current Issues in Molecular Biology showed that Copper Tripeptide-1 directly enhanced elastin expression and secretion in dermal fibroblasts. The researchers then combined it with elastase inhibitors and scaffold-reinforcing compounds and demonstrated visible restoration of elastic fiber architecture in UV-damaged human skin biopsies. Scanning electron microscopy confirmed the fiber network was rebuilt, not just protected.

But here is something most ingredient marketing skips. GHK-Cu does not just build. It also dismantles. Pickart’s work showed it regulates both matrix metalloproteinases, which are enzymes that break down damaged ECM proteins, and their natural inhibitors, called TIMPs. This means GHK-Cu is a remodeling coordinator, not a bulldozer or a hoarder. It clears damaged collagen to make room for fresh synthesis. That dual action — degrade old, build new — is what separates repair from scar formation.

Two: Anti-Inflammatory and Antioxidant Defense

Chronic low-grade inflammation drives skin aging. Scientists call it inflammaging. GHK-Cu suppresses it at multiple checkpoints. A 2026 study from Yunnan Botanee Bio-Technology published in the European Journal of Pharmacology tested GHK-Cu in a zebrafish larvae model of acute inflammation. The peptide significantly reduced the migration of neutrophils and macrophages to inflamed tissue. It suppressed three key pro-inflammatory cytokines — TNF-alpha, IL-one-beta, and IL-six — while boosting the anti-inflammatory cytokine IL-ten. It also cut reactive oxygen species and nitric oxide levels while improving superoxide dismutase activity. The pathway analysis pointed to JAK1 downregulation as a likely mechanism.

This anti-inflammatory effect matters for cosmetic users. UV-induced inflammation drives photoaging. Pollution-triggered inflammation drives urban skin aging. An ingredient that quiets these pathways while simultaneously rebuilding the matrix is doing two jobs that normally require separate products.

Three: Mitochondrial Protection and Cellular Longevity

This is the newest discovery and the most fundamental. A 2026 study from Yunnan University published in Biogerontology tested GHK-Cu in Caenorhabditis elegans, a microscopic worm that scientists use as a model organism for aging research. GHK-Cu extended the worms’ lifespan and improved multiple aging markers: better movement, better feeding rhythm, reduced age-pigment accumulation, and enhanced resistance to both oxidative and thermal stress. At the cellular level, GHK-Cu preserved mitochondrial membrane potential, prevented age-related mitochondrial fragmentation, and shifted mitochondrial dynamics toward fusion rather than fission. It also activated two longevity pathways — DAF-16 and SKN-1 — and upregulated the antioxidant genes sod-three, gst-four, and gcs-one.

For a skincare ingredient to show these effects at the cellular aging level is significant. It suggests GHK-Cu is not just patching wrinkles. It is addressing one of the nine hallmarks of aging — mitochondrial dysfunction — directly in skin cells. The same pathways exist in human dermal fibroblasts.

The Delivery Problem That Most Formulations Ignore

GHK-Cu is water-soluble and carries a two-plus charge from the copper ion. Your stratum corneum — the outermost layer of skin — is a lipid-rich barrier designed to keep water out and charged molecules out. This is the central paradox of peptide skincare: the molecules that signal repair cannot easily reach the fibroblasts that need the signal.

Small peptides in the three-hundred to five-hundred dalton range can theoretically penetrate intact skin. But “theoretically” does not mean efficiently. A 2025 review in the International Journal of Molecular Sciences examined acetyl hexapeptide-eight, another small cosmetic peptide, and concluded that its hydrophilicity and molecular size made effective dermal delivery challenging. GHK-Cu faces the same problem with the added complication of its copper charge. Without a delivery system — liposomes, penetration enhancers, or microneedling — most of what you apply sits on the surface and gets washed off.

This is why formulation technology matters more than ingredient concentration. A two percent GHK-Cu serum in a basic water-glycerin base may deliver less copper peptide to the dermis than a point-five percent formula encapsulated in tiered-release vesicles. The LG study used a sophisticated multi-target approach combining Copper Tripeptide-1 with elastase inhibitors and scaffold-reinforcing compounds. The Botanee study used GHK-Cu in solution for zebrafish immersion, which bypasses the barrier question entirely. For topical human use, a 2024 study in Dermatologic Surgery demonstrated that Tiered-Release Vesicles delivered large peptides two to five times more efficiently into ex vivo human skin than optimized liposomes. The delivery platform is the product. The peptide is just the payload.

Microneedling changes the equation entirely. When you create microscopic channels through the stratum corneum, peptides bypass the lipid barrier and enter the dermis directly. This is why clinical microneedling combined with GHK-Cu produces faster and more dramatic results than topical application alone. A 2026 review in Facial Plastic Surgery Clinics of North America described how fractional and energy-based microneedling platforms overcome the stratum corneum barrier to facilitate substantive dermal penetration of bioactive peptides through device-assisted drug delivery. The channel depth — typically point-five to one-point-five millimeters — reaches the papillary and upper reticular dermis, exactly where fibroblasts sit. The effect is temporary, with channels closing within hours, but those hours are a direct express lane for peptides that would otherwise spend days trying to diffuse through intact barrier lipids.

This barrier issue explains one of the most common complaints about copper peptide serums: they feel like they are not doing anything for weeks, then suddenly results appear. The lag is not the biology. The biology activates within hours of the peptide reaching fibroblasts. The lag is the physics of penetration — slow, cumulative, and concentration-dependent. Every application that reaches the dermis adds to the signal pool. Every application that sits on the surface and gets wiped off contributes nothing. Consistency is not a nice-to-have with GHK-Cu. It is the difference between the peptide working and the peptide being an expensive blue rinse.

Clinical Evidence: From Wound Beds to Wrinkle Depths

The wound healing literature is where GHK-Cu first proved itself. Pickart’s early work in the nineteen-eighties and nineties showed GHK-Cu accelerated wound closure in rats, mice, pigs, and dogs. It recruited immune cells and endothelial cells to injury sites and promoted angiogenesis — the formation of new blood vessels. A 2026 study in Materials Today Bio took this further, embedding GHK-Cu in a glucose-oxidase-loaded hydrogel for diabetic wound healing. The copper peptide activated a cascade reaction that reduced local hyperglycemia, generated oxygen from hydrogen peroxide, and simultaneously stimulated antibacterial activity, tissue repair, and new blood vessel formation. This is wound healing at the level of metabolic engineering.

In cosmetic dermatology, the evidence is smaller in scale but consistent in direction. Pickart’s 2015 review summarized the cosmetic findings: GHK-Cu tightened loose skin, improved elasticity and firmness, reduced fine lines and wrinkles, and decreased photodamage and hyperpigmentation. These were human studies using topical formulations, not cell cultures. A 2026 gerontology review in Frontiers in Aging identified GHK-Cu as one of nine therapeutic peptides with demonstrated applications in dermal regeneration and healthy aging.

The hair literature provides an interesting data point. A 2018 study from Japan published in the Journal of Clinical and Aesthetic Dermatology treated eighteen thousand nine hundred eighteen male patients with androgenetic alopecia using a combination therapy that included injectable copper tripeptide. Ninety-six percent reported satisfaction at six months. The copper peptide was one component of a multi-ingredient solution, so attribution is not clean. But the safety signal across that many patients is notable — minor complications occurred in just over four percent of cases, and no treatment-related adverse events were observed.

Expert Insight: What Experienced Formulators Know

Let me share three things that experienced peptide formulators understand and that ingredient labels rarely tell you.

First, concentration is not potency. GHK-Cu is biologically active at very low concentrations — nanomolar to low micromolar. The body’s natural plasma concentration is roughly two hundred nanograms per milliliter at age twenty. Loading a serum with two percent GHK-Cu may look good on a label, but beyond a certain threshold you are not getting more biological activity. You are just getting more blue color — GHK-Cu is intensely blue, which makes for dramatic marketing but tells you nothing about efficacy. What matters is how much reaches the dermis in active form, not how much is in the bottle.

Second, GHK-Cu degrades in water. The copper ion catalyzes oxidation reactions in aqueous solution. Over weeks to months, the peptide backbone can hydrolyze and the copper can dissociate. A freshly manufactured GHK-Cu serum and the same bottle six months later are not the same product. This is one reason lyophilized, or freeze-dried, GHK-Cu powders that you reconstitute at home have gained traction. They sidestep the stability problem entirely. But they add a compliance problem — will the average consumer mix the powder correctly and use it before it degrades?

Third, not all blue serums contain active GHK-Cu. The deep blue color of genuine GHK-Cu is easy to fake with synthetic dyes. A brand can put copper chloride and a generic tripeptide in a bottle with blue dye number one and label it “Copper Peptide Serum.” It will look identical. It will cost a fraction to produce. It will have none of the biological activity. The only reliable signal is third-party testing — a certificate of analysis from an independent lab confirming the presence and concentration of GHK-Cu at the time of manufacture. Without that, you are buying blue water.

GHK-Cu in Your Routine: Practical Context

So how do you actually use this peptide? The science points to a few practical rules.

GHK-Cu works best on clean, slightly damp skin. Apply it after cleansing and before heavier creams or oils. The water-soluble peptide needs some moisture to partition into the stratum corneum. A completely dry face reduces penetration. Give it two to three minutes to absorb before layering anything on top.

Do not mix GHK-Cu with strong acids in the same routine. Low-pH products — glycolic acid, salicylic acid, high-concentration vitamin C as ascorbic acid — can strip the copper from the peptide or alter the peptide’s charge, reducing activity. Use acids in the morning and GHK-Cu at night. Or alternate nights. Retinol and GHK-Cu can coexist in the same evening routine because retinol works through nuclear receptors while GHK-Cu works through extracellular signaling and gene expression — they operate on different tracks. But watch for irritation. Both are active ingredients with real biological effects.

GHK-Cu pairs well with other peptides. Signal peptides like Matrixyl work through a different receptor pathway — they activate TGF-beta signaling to boost collagen, while GHK-Cu modulates a broader set of repair genes. Neurotransmitter-inhibiting peptides like Argireline target muscle contraction, which is a completely separate mechanism from tissue remodeling. Using GHK-Cu alongside these other peptide classes creates complementary coverage — one rebuilds the matrix, one boosts collagen production more directly, and one reduces the mechanical stress that creates expression lines in the first place.

Expect results on a timeline of eight to twelve weeks, not days. GHK-Cu remodels tissue. Tissue remodeling is slow. The fibroblast needs to receive the signal, transcribe the genes, produce the procollagen, secrete it into the extracellular space, and then the procollagen needs to be cleaved and assembled into mature collagen fibrils. That entire pipeline takes weeks. Clinical studies on GHK-Cu typically measure outcomes at eight to twelve weeks. Anyone promising visible results in three days is selling something else.

七种肽类的复配逻辑

Mizon官方宣称这款精华含有七种肽类的复配体系，且全部源自植物。虽然具体成分列表尚未完全公开，但从行业惯例来看，七肽体系很可能包含以下几个方向的覆盖：第一类是信号肽，比如Matrixyl系列（棕榈酰寡肽），用于刺激胶原蛋白和弹性蛋白的合成。第二类是载体肽，帮助其他活性成分更有效地渗透到皮肤深层。第三类是神经递质抑制肽，类似Argireline（乙酰基六肽-8）的作用机制，通过抑制肌肉收缩来减少表情纹。

七种肽类覆盖三个方向的好处是什么？一瓶精华同时解决胶原蛋白生成、成分渗透和表情纹控制三个问题。对于消费者来说，这是真正的”多效合一”——不需要在Argireline和Matrixyl之间做选择。

但这里有一个行业内的常见反模式需要注意：多肽复配不等于越多越好。肽类分子之间的相互作用复杂，某些肽类在同一配方中可能互相竞争皮肤表面的受体位点。有经验的配方师会告诉你，七肽体系的关键不是数量，而是每一种肽类的浓度是否达到了有效阈值。如果为了凑足”七种”的营销卖点而降低每种肽类的添加量，效果反而不如两到三种高浓度肽类的组合。

Mizon作为有二十年配方经验的品牌，应该不会犯这个低级错误。但消费者在选购其他品牌的”多肽”产品时，可以把这一点作为判断标准——看产品是否标明了具体肽类种类和大致浓度，而不是只看宣传上的数字。

纯素肽类的技术与市场意义

这款精华的另一个关键信息是”Vegan”——所有肽类来自植物源。传统肽类生产多使用化学合成方法，本身并不涉及动物成分。Mizon刻意强调植物源肽类，更多是面向纯素护肤消费群体的市场定位。

从技术角度来说，植物源肽类与合成肽类在分子结构上可以做到完全一致，功效上不应有本质区别。差别主要在提取工艺和成本控制上。植物源肽类的提纯难度更高，成本相应也更贵。

这个趋势在K-Beauty中并不孤立。Glow Recipe的Prickly Pear Peptide Mucin Serum同样使用了植物提取物+肽类的组合，COSRX的Blue Peptide系列也强调了温和植物配方。整个K-Beauty品类正在向”成分功效+环保理念”的复合方向转型——不仅要有效，还要”道德”。这对于面向年轻消费者的品牌来说，是一个明确的趋势信号。

对于肽类护肤消费者的实际意义

Mizon的7 Vegan Peptide Booster Serum最直接的影响是：肽类护肤的价格门槛将进一步降低。Mizon产品的价格区间通常在十到二十五美元之间，远低于SkinCeuticals或ZO Skin Health的百元级定价。这让预算有限的消费者也能体验到多肽复配的护肤效果。

从品类发展的角度看，Mizon的入局意味着肽类已经完成了从”小众高端成分”到”大众基础成分”的转型。当大众市场的K-Beauty品牌开始将七肽作为标准配置时，肽类在护肤品中的地位已经类似于当年的维生素C和透明质酸——不再是差异化卖点，而是基本配方要求。

对于中国市场的消费者，Mizon在电商平台的覆盖很好，这款精华应该很快就能通过天猫、京东等渠道买到。如果你想先体验肽类的效果，又不想一开始就花高价，Mizon的这款产品是一个性价比很高的切入点。我们的入门套装也提供了不同肽类成分的搭配试用方案，可以帮助你找到最适合自己的肽类成分。

进一步阅读

最后审阅：2026年7月。Peptide Proof编辑团队。来源：Yahoo Finance，Glossy

Glow Recipe推出Prickly Pear肽类Mucin精华：K-Beauty大牌的肽类新布局

Applications

Peptide Proof Editorial

-

July 10, 2026

0

Glow Recipe推出Prickly Pear肽类Mucin精华：K-Beauty大牌的肽类新布局

Glow Recipe，这个凭借Watermelon Glow系列火遍全球的K-Beauty品牌，最近又有了新动作。据L’Officiel新加坡独家报道，该品牌即将推出全新的Prickly Pear Peptide Mucin Serum——一款将仙人掌籽提取物、肽类和Mucin结合在一起的精华液。这不仅仅是又一款新品发布，更是Glow Recipe正式进军肽类护肤领域的明确信号。

Glow Recipe在2023年就已经进入了肽类护肤赛道，但这次的新品似乎更加激进。Prickly Pear（仙人掌果）富含抗氧化剂和必需脂肪酸，Mucin提供深层保湿和修复，肽类则负责刺激胶原蛋白生成、改善皮肤弹性。三种核心成分的组合，瞄准的是”屏障修复+抗衰老”这个正在快速增长的细分市场。

为什么Glow Recipe选择现在加码肽类？

整个美妆行业正在经历一波肽类热潮。据Spate市场研究的数据，”peptide therapy”在Google上的搜索量同比增长了百分之二百八十一，在TikTok上增长百分之四百五十九，在Instagram上增长百分之四百一十二。这还只是今年四月初的数据。Spate预测未来一年整个品类还将增长百分之三十三。

Glow Recipe不是第一个吃螃蟹的品牌。早在2020年，K-18通过肽类发膜打开了市场，最终被联合利华以超过十亿美元收购。这个”肽类造富”的故事让整个行业重新审视了肽类的潜力。LS迈克尔公司创始人Lorne Lucree在Glossy的采访中提到，肽类原料供应商现在正在大量开发新分子，准备投入到新配方中。品牌层面的竞争，实际上反映的是供应链上游的创新在加速。

Prickly Pear Peptide Mucin的组合价值在哪里？

这款精华液最值得关注的点是成分协同策略。仙人掌果提取物富含维生素E和抗氧化剂，能帮助皮肤抵抗环境压力。Mucin提供的是长期修复和保湿基础——这在亚洲护肤传统中已经有几十年的验证。肽类则补充了Mucin不擅长的领域：胶原蛋白信号调节和皱纹改善。

说一个很多人会忽视的坑：多肽类产品和其他活性成分的配伍问题。肽类分子在配方中相当敏感，遇到不当的pH值或不相容的成分容易降解失活。一款同时含有Mucin和肽类的产品，对配方稳定性的要求比单一活性成分的产品高得多。Glow Recipe既然选择在这个时间点推出这样的复合配方，说明他们在配方稳定性上做了足够的功课。

那么这对消费者意味着什么？如果你已经在使用单一的肽类精华，这款产品提供的是”多效合一”的替代方案。但要注意，肽类和酸类成分（如果酸、水杨酸）不宜同时使用——酸环境会破坏肽类结构。如果早晚护肤流程中涉及去角质产品，建议错开使用时间。

对于想从基础保湿进阶到抗老护肤的用户来说，这款精华是一个不错的入门选择。它兼顾了保湿（Mucin）、修复（仙人掌果）和抗老（肽类）三个维度，比纯肽类精华的适应期更短。

Glow Recipe的产品线延伸战略

Glow Recipe的产品策略一直很清晰：从明星单品（Watermelon Glow）出发，逐步延伸到新的活性成分赛道。这次选择肽类+Mucin的组合，既延续了品牌对亚洲护肤成分的深度理解（Mucin是K-Beauty的标志性成分），又借力了肽类在全球范围内的高增长趋势——这是一个相当聪明的产品定位。

从商业角度看，Glow Recipe的这一步棋也反映了一个更大的趋势：K-Beauty品牌正在从”概念营销”向”成分科技”转型。讲一个好故事已经不够了，品牌需要有真实可验证的活性成分组合。肽类恰好提供了一个兼具科学背书和消费者认知的优质选项。

K-Beauty肽类护肤的未来

Glow Recipe不是唯一加码肽类的K-Beauty品牌。COSRX刚刚推出了Blue Peptide系列，Mizon也宣布了7种肽类复合精华的全球上市。整个K-Beauty品类正在经历一轮成分升级——从基础的保湿和舒缓，向具有明确抗老信号功能的肽类成分过渡。

对于中国市场的消费者来说，这意味着未来六到十二个月内，会有更多以肽类为核心的韩系护肤新品进入视野。价格方面，Glow Recipe的高端定位可能不会有很大惊喜，但COSRX和Mizon等更亲民的品牌会提供更多选择。

如果你对肽类护肤感兴趣，但又不想一上来就投入大牌高价产品，我们的多肽精华液系列——包括Argireline精华和Matrixyl精华——提供了纯成分级的入门选择。对于想要全面体验肽类护肤效果的用户，我们的入门套装是一个零压力的起点。

进一步阅读

最后审阅：2026年7月。Peptide Proof编辑团队。来源：Glossy，L’Officiel Singapore

Argireline Science: How Peptides Relax Expression Lines

Research & Discovery

Peptide Proof Editorial

-

July 9, 2026

0

Argireline Science: How Peptides Relax Expression Lines

Every time you squint, frown, or raise an eyebrow, a chain of molecular events fires inside your facial muscles. Acetylcholine floods across a synapse. Muscle fibers contract. Over decades, those repeated contractions etch permanent lines into your skin. The cosmetic industry spent a century looking for a way to slow this process without injecting anything. Then in 2002, a team in Spain published a paper on a six-amino-acid chain that could interrupt the signal before it reached the muscle. They called it Argireline. The beauty press called it Botox in a bottle. Twenty-four years and dozens of studies later, this peptide remains one of the most studied and most misunderstood ingredients in skincare. Let me walk you through what the science actually says.

The Biology Problem: Why Muscles Create Wrinkles

Your face has forty-three muscles. They pull on skin that thins with age. Collagen production drops by about one percent per year after age twenty-five. Elastin fibers fray and snap. The combination is brutal. Weaker skin plus repeated muscle pulls equals permanent creases. This is why expression lines appear in predictable places. The “eleven” between your brows comes from the corrugator muscle. Crow’s feet trace the pull of the orbicularis oculi around your eyes. Forehead lines map the frontalis muscle pulling upward.

The neuromuscular junction is the bottleneck. That’s the microscopic gap where a nerve ending meets a muscle fiber. When your brain decides to frown, an electrical signal races down the motor neuron. At the terminal, the signal triggers tiny sacs called synaptic vesicles. These vesicles are packed with acetylcholine. They need to fuse with the nerve cell membrane to dump acetylcholine into the gap. That fusion step is the choke point. Block it and the signal never reaches the muscle.

Botulinum toxin blocks this step by cleaving SNARE proteins, which are the molecular machinery that docks vesicles to the membrane. The effect is dramatic. It can last three to six months. But it requires an injection through the skin, through the muscle fascia, and into the nerve terminal. A topical ingredient faces a much harder problem. It has to cross the stratum corneum first, then find its way to the neuromuscular junction, and then somehow interfere with that same docking machinery. Argireline attempts exactly this.

The SNARE Complex: Where the Signal Gets Intercepted

Here’s the key data point. Neurotransmitter release depends on three proteins forming a tight bundle called the SNARE complex. Think of it as a molecular zipper. One protein, SNAP-25, lives on the nerve cell membrane. Two others, syntaxin and synaptobrevin, anchor to the membrane and the vesicle respectively. When calcium ions rush into the nerve terminal, these three proteins zip together. The zipping pulls the vesicle so close to the membrane that they fuse. Acetylcholine spills out. The muscle contracts.

Argireline, whose chemical name is acetyl hexapeptide-8, is a fragment of SNAP-25. Specifically, it copies amino acids twelve through seventeen of the protein’s N-terminal domain. The sequence is acetyl-glutamic acid-glutamic acid-methionine-glutamine-arginine-arginine-amide. Those six amino acids, in that precise order, are what allows SNAP-25 to recognize its partners in the SNARE complex. When you flood the synapse with free copies of this fragment, those copies compete with the real SNAP-25 for binding positions. The real SNAP-25 gets crowded out. The SNARE zipper doesn’t form properly. Fewer vesicles dock and fuse. The muscle receives a weaker signal.

This is fundamentally different from botulinum toxin. Botox cleaves and permanently disables SNARE proteins. The neuron has to grow new ones, which takes months. Argireline doesn’t destroy anything. It competes. The effect is subtler and reversible. When you wash off your serum, the free peptide fragments dissipate. Full neurotransmitter release resumes. This is both the strength and the limitation of the approach. You get relaxation without paralysis, daily application without a needle. But you also get a milder effect that requires consistent use. Argireline is not the only peptide competing for SNARE binding positions. Syn-Ake, whose full chemical name is dipeptide diaminobutyroyl benzylamide diacetate, targets the acetylcholine receptor on the muscle side of the junction rather than the SNARE complex on the nerve side. It mimics waglerin-1, a peptide found in the venom of the Wagler’s pit viper. Snap-8, or acetyl octapeptide-3, is an eight-amino-acid extension of the same SNAP-25 fragment that Argireline copies. The extra two amino acids give it a slightly different binding profile. Inylin targets the same SNARE complex but through a different SNAP-25 epitope. Vialox, or pentapeptide-3, blocks the acetylcholine receptor like Syn-Ake but with a different binding affinity. Each of these neurotransmitter-inhibiting peptides works at a slightly different point along the neuromuscular signaling cascade. The implication for formulators is clear. Combining two or three of these peptides can create a broader blockade than any single one alone. The Bai team’s 2026 triple-peptide nanoparticle exemplifies this strategy.

A 2026 study from Bai and colleagues at Biomaterials Advances pushed this competition concept further. They built a triple-peptide nanoparticle combining Argireline with Syn-Ake, which is dipeptide diaminobutyroyl benzylamide diacetate, and μ-conotoxin, a peptide from cone snail venom. The three peptides target different points along the neuromuscular signaling pathway. Argireline blocks the SNARE complex at the pre-synaptic terminal. Syn-Ake mimics waglerin-1, a peptide from temple viper venom, and blocks the acetylcholine receptor on the muscle side. μ-Conotoxin blocks voltage-gated sodium channels, preventing the electrical signal from even reaching the terminal. The researchers loaded all three into a single nanostructure via hydrophobic interactions and hydrogen bonding. The result was a synergistic blockade. The self-assembled nanoparticles showed significantly stronger neuromuscular inhibition than any single peptide alone.

The Delivery Problem: Getting Peptides Where They Need to Go

The stratum corneum exists to keep things out. It’s a brick wall of dead skin cells embedded in a lipid mortar. Molecules larger than about five hundred daltons struggle to cross it. Argireline has a molecular weight of roughly eight hundred and eighty-nine daltons. That’s well above the five-hundred-dalton rule. On paper, it shouldn’t penetrate at all. In practice, it does. Partly. The question is how much, and that question has driven an entire subfield of cosmetic formulation science.

The Bai team addressed this by pairing their peptide nanoparticles with a deep eutectic solvent. DES is a mixture of betaine, glycerol, and propylene glycol that temporarily disrupts the lipid organization of the stratum corneum. It doesn’t damage the skin permanently. It just creates transient gaps that molecules can slip through. Their data showed that the DES formulation increased peptide penetration significantly compared to aqueous solutions. This is consistent with a broader trend in the literature. The future of peptide skincare isn’t better peptides. It’s better delivery.

Now here’s where microneedling enters the picture. Feng and colleagues published a study in the International Journal of Biological Macromolecules in 2026. They built dissolving microneedles from hyaluronic acid and polyvinyl alcohol. Each microneedle tip carried acetyl hexapeptide-8 at a twenty percent loading capacity. When pressed into the skin, the HA tip dissolves and releases the peptide directly into the epidermis. No stratum corneum barrier to cross. The microneedles were tested on Bama miniature pig skin, which has a stratum corneum thickness similar to human facial skin. The release profile showed sustained peptide delivery over several hours. This approach solves the most fundamental weakness of topical Argireline. It bypasses the five-hundred-dalton gate entirely.

Rong and colleagues reported yet another angle in Bioactive Materials in 2026. They developed fluorinated cell-penetrating peptides that act as molecular chaperones. When combined with bioactive peptides like Argireline, these fluorous tags dramatically improved transdermal penetration. The fluorine atoms create a lipophobic effect that helps the peptide complex partition through cell membranes. It’s an elegant piece of chemistry. The penetrating peptide escorts the active peptide across barriers that would otherwise stop it cold.

What the Clinical Studies Actually Show

Let me break this down. The 2026 Zhu study in the International Journal of Cosmetic Science is the most comprehensive clinical data we have on topical Argireline in a combination serum. The formula contained acetyl hexapeptide-8 plus Syn-Ake, gluconolactone, niacinamide, and laminaria extract. The study ran two separate clinical trials. Trial one enrolled fifty participants and measured static wrinkles and skin quality. Trial two enrolled forty-two participants and focused specifically on dynamic wrinkles, which are the ones formed by muscle movement.

The results tell a nuanced story. The combination serum produced significant improvements in multiple biomarkers. Collagen types one, three, four, and seventeen all increased. Matrix metalloproteinase-1, an enzyme that breaks down collagen, decreased. Elastic fiber content went up. These are measurable structural changes, not just surface smoothing. On the clinical side, both static and dynamic wrinkles showed visible improvement. The study measured wrinkle depth reductions and skin texture improvements using instrumental analysis alongside investigator grading. But here’s the thing. The study tested the full combination, not Argireline alone. We can’t isolate exactly how much of the benefit came from the peptide versus the niacinamide or the alpha-hydroxy acid. The gluconolactone in the formula is a polyhydroxy acid that exfoliates and hydrates. The niacinamide is a well-documented anti-aging active with its own clinical evidence base. The laminaria extract adds antioxidant and moisturizing properties. Argireline was doing real work in that formula. The mechanistic logic is sound and the ex-vivo biomarker data supports anti-aging activity at the molecular level. But anyone who tells you this study proves Argireline monotherapy works is overstating the evidence. The study proves the combination works. That’s still valuable. It’s just not the same thing.

This pattern runs through the literature. The 2026 Dikmen Kucuk study used Argireline as a benchmark comparator against Ganoderma lucidum mushroom extract. Argireline served as the positive control because it’s considered a well-established anti-wrinkle active. That peer recognition matters. When researchers across institutions independently choose your ingredient as the standard of comparison, you’ve earned a place in the evidence base. But the shelf of placebo-controlled, Argireline-monotherapy trials is thinner than marketers would like you to believe.

The safety picture is much clearer. The Cosmetic Ingredient Review Expert Panel published its safety assessment of acetyl hexapeptide-8 amide in the International Journal of Toxicology in 2025. Their conclusion was unambiguous. The ingredient is safe in cosmetics at concentrations up to zero point zero zero five percent. That’s the ceiling for what the available data supports. Many commercial serums contain higher concentrations. Whether those higher levels carry any additional risk is not yet established by the published evidence. The panel noted explicitly that data were insufficient to determine safety above the zero point zero zero five percent threshold.

What Experienced Formulators Know That Marketing Won’t Tell You

First anti-pattern. Concentration isn’t everything. Most consumer conversations about Argireline revolve around the percentage on the label. Ten percent Argireline must be better than five percent, right? Not necessarily. Peptide penetration through the stratum corneum follows a saturation curve. Above a certain concentration, the gradient driving passive diffusion plateaus. Additional peptide molecules just sit on the skin surface until you wash them off. The formulation vehicle matters more than the percentage. A five percent Argireline in a penetration-optimized delivery system will outperform a ten percent solution in a simple water-glycerin base. The label percentage is the number least correlated with actual results.

Second anti-pattern. Peptide stability is the silent killer. Acetyl hexapeptide-8 contains a methionine residue. Methionine oxidizes when exposed to air, light, or trace metals. An oxidized methionine changes the peptide’s three-dimensional conformation and destroys its ability to mimic the SNAP-25 binding domain. Your Argireline serum is degrading from the moment you open the bottle. Airless pumps matter. Opaque packaging matters. Refrigeration extends active life. But almost no consumer brand talks about this because the solution conflicts with shelf-appeal packaging and room-temperature retail display.

Third anti-pattern. The daily application cycle matters more than people realize. Argireline competes reversibly with endogenous SNAP-25. The half-life of that competition depends on how fast the body clears the peptide from the synaptic space. There’s no published pharmacokinetic data on cutaneous acetyl hexapeptide-8 half-life in human facial tissue. But the clinical studies showing efficacy all used twice-daily application. Once-daily use may simply not maintain a high enough concentration at the neuromuscular junction to sustain SNARE complex interference through a full circadian cycle.

How Argireline Fits Into a Broader Anti-Aging Strategy

Argireline addresses one aging mechanism. Muscle-driven wrinkle formation. Skin aging involves at least six other mechanisms. Collagen loss from fibroblast senescence. Elastin degradation from UV exposure. Oxidative damage from free radicals. Glycation that cross-links proteins. Lipid barrier depletion. Cellular water loss. Each mechanism needs its own intervention. This is why single-ingredient approaches disappoint.

The most thoughtful regimens pair Argireline with a signal peptide like Matrixyl, whose chemical name is palmitoyl pentapeptide-4, or Matrixyl 3000, which is palmitoyl tripeptide-1 plus palmitoyl tetrapeptide-7. Signal peptides tell fibroblasts to produce more collagen. Neurotransmitter-inhibiting peptides tell muscles to relax. They work on completely different pathways with no mechanistic overlap. The combination makes sense. So does pairing Argireline with copper peptides like GHK-Cu, which support wound healing and tissue remodeling through an entirely separate set of cellular receptors.

But what most people miss is the timing. Neurotransmitter-inhibiting peptides work within minutes to hours. Signal peptides take weeks to months because you’re waiting for new collagen synthesis, which is a slow biological process. The visible wrinkle improvement you see in the first two weeks of using a combination serum is almost entirely the neurotransmitter-inhibiting component doing its job. The collagen-boosting component hasn’t kicked in yet. Patients misinterpret this as “the product stopped working” when in reality the fast-acting component is maintaining steady-state while the slow-acting component is ramping up. Understanding that timeline changes how you evaluate results.

One more practical note. Argireline works best on expression lines formed by repetitive muscle movement. The glabellar lines between the eyebrows. The crow’s feet at the lateral canthus. The horizontal forehead creases. It does nothing for nasolabial folds, which are caused by fat pad descent and soft tissue volume loss. It does nothing for perioral lines caused by lip pursing and environmental damage. Using Argireline on wrinkles it wasn’t designed to treat is the most common consumer error, and it’s one that generates thousands of negative reviews that have nothing to do with the ingredient’s actual capability.

铜肽三步曲：这意味着什么

从产品设计的角度来看，三步骤铜肽系统的意义在于”协同放大”。单独的铜肽精华能促进胶原蛋白合成，但如果清洁步骤中有干扰铜离子吸收的成分（比如强酸或螯合剂），效果就会打折扣。CKYN的三步系统保证了每一步都兼容铜肽的最佳吸收条件，减少了用户搭配不当的风险。

很多人在用铜肽时都会遇到一个问题——它和某些成分不能混用。维生素C在同一个护肤流程里会氧化铜肽，A醇的酸性环境也会影响铜肽的稳定性。所以一个从头到尾围绕铜肽设计的系统，确实解决了实际使用中的痛点。

但反过来思考，这也有另一面——品牌在锁定用户。如果你买了CKYN的三步系统，就很难再单独替换其中某一个步骤，因为体系中每一步都针对铜肽做了配方优化。这相当于把用户锁在了自己的生态里。

数据与市场信号

铜肽能否从单一成分走向完整的护肤体系，这个趋势本身就是一个有价值的市场信号。过去几年肽类护肤的增长主要集中在信号肽（Matrixyl系列）和神经递质抑制肽（Argireline），铜肽虽然数据扎实但市场声量一直偏小。

现在越来越多品牌开始关注铜肽。Neurogan推出了GHK-Cu精华，YSE Beauty的新品中也加入了铜肽成分。CKYN的”三步骤系统”则把铜肽从一个原料级成分升级为有完整故事线的品牌IP。如果这个模式成功，我们可能会看到更多单一肽类品牌的诞生——比如围绕Matrixyl的品牌、围绕Argireline的品牌。

这和补剂行业的发展路径很像。十年前是单一成分（如鱼油、维生素D），现在是系统化组合（如每日健康包）。肽类护肤很可能也会走同样的路。

专家视角

很多人在买铜肽产品时犯的第一个错误是只看浓度。但铜肽GHK-Cu的活性取决于它的稳定性配方，而不只是添加量。一个好的铜肽产品需要合适的pH值（五到六之间）、抗氧化保护（防止铜离子氧化）和适当的透皮增强系统。浓度再高，如果配方不稳定，皮肤根本吸收不到活性成分。

如果你对GHK-Cu铜肽本身感兴趣，我们的GHK-Cu冻干粉是一个纯成分的替代方案——不含任何配方添加剂，直接从原料层面体验铜肽的效果。可以作为CKYN系统的补充，也可以单独搭配你喜欢的基液使用。

延伸阅读

最后审阅：2026年7月。Peptide Proof编辑团队。信息来源：Lincoln Journal, Glossy, CKYN LLC新闻稿。

Aramis

peptide-proof

七肽复配：配方策略的深层逻辑

素食友好：肽类美容的伦理化趋势

Mizon进入肽类赛道对市场意味着什么

延伸阅读

COSRX为什么选择现在加码肽类？

蓝肽精华液的核心竞争力在哪里？

Prime Day促销背后的渠道策略

延伸阅读

Eight New Launches Tell the Story

Expert Insight

Peptide Patches: The New Frontier

What the Trend Means for Consumers

Further Reading

Why This Launch Matters for the Peptide Skincare Market

Expert Insight

What This Means for the Broader Category

Further Reading

The Stratum Corneum — Your Skin’s Brick Wall

Why Peptides Have It Worse Than Other Actives

The Numbers Don’t Lie — What Penetration Studies Actually Show

Chemical Solutions — Palmitoylation, CPPs, and Permeation Enhancers

The Carrier Revolution — Microemulsions, Liposomes, and TRVs

Physical Routes — Microneedles, Iontophoresis, and Laser-Assisted Delivery

Expert Insight — What the Formulation Labels Don’t Tell You

What This Means for Your Routine

Further Reading

Sources

技术专利对肽类护肤品赛道意味着什么？

大众市场的肽类普及还有多远？

延伸阅读

Cetaphil为什么要做肽类抗衰老？

Cetaphil入局肽类赛道意味着什么？

延伸阅读

What GHK-Cu Actually Is

The Triad of Tissue Repair: How GHK-Cu Works

One: Extracellular Matrix Remodeling

Two: Anti-Inflammatory and Antioxidant Defense

Three: Mitochondrial Protection and Cellular Longevity

The Delivery Problem That Most Formulations Ignore

Clinical Evidence: From Wound Beds to Wrinkle Depths

Expert Insight: What Experienced Formulators Know

GHK-Cu in Your Routine: Practical Context

Further Reading

七种肽类的复配逻辑

纯素肽类的技术与市场意义

对于肽类护肤消费者的实际意义

进一步阅读

为什么Glow Recipe选择现在加码肽类？

Prickly Pear Peptide Mucin的组合价值在哪里？

Glow Recipe的产品线延伸战略

K-Beauty肽类护肤的未来

进一步阅读

The Biology Problem: Why Muscles Create Wrinkles

The SNARE Complex: Where the Signal Gets Intercepted

The Delivery Problem: Getting Peptides Where They Need to Go

What the Clinical Studies Actually Show

What Experienced Formulators Know That Marketing Won’t Tell You

How Argireline Fits Into a Broader Anti-Aging Strategy

Further Reading

Sources

铜肽三步曲：这意味着什么

数据与市场信号

专家视角

延伸阅读

peptide-proof